ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT04186871

Public ClinicalTrials.gov record NCT04186871. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Assess the Efficacy and Safety of Branebrutinib Treatment in Subjects With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Subjects With Active Rheumatoid Arthritis

Study identification

NCT ID
NCT04186871
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
119 participants

Conditions and interventions

Interventions

  • abatacept Drug
  • branebrutinib Drug
  • branebrutinib placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 6, 2020
Primary completion
Dec 4, 2022
Completion
Dec 4, 2022
Last update posted
Jan 15, 2024

2020 – 2022

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
38
Facility City State ZIP Site status
Local Institution - 0019 Phoenix Arizona 85032
Local Institution - 0002 Covina California 91723
Local Institution - 0024 Encino California 91436
Local Institution - 0034 San Diego California 92108
Local Institution - 0032 Upland California 91786
Local Institution Brandon Florida 33511
Local Institution - 0062 DeBary Florida 32713
Local Institution - 0035 Hialeah Florida 33016
Local Institution Jacksonville Florida 32209
Local Institution - 0029 Plantation Florida 33324
Local Institution - 0009 Lawrenceville Georgia 30046
Local Institution - 0014 Skokie Illinois 60076
Local Institution Evansville Indiana 47715
Local Institution - 0005 Monroe Louisiana 71203
Local Institution - 0041 Ann Arbor Michigan 48109
Local Institution - 0082 Grand Blanc Michigan 48439
Local Institution - 0096 St Louis Missouri 63131
Local Institution - 0040 St Louis Missouri 63141
Local Institution - 0056 Lincoln Nebraska 68516
Local Institution - 0007 Las Vegas Nevada 89119
Local Institution Manhasset New York 11030
Local Institution New York New York 10016
Local Institution - 0008 Charlotte North Carolina 28204
Local Institution - 0006 Salisbury North Carolina 28144
Local Institution Minot North Dakota 58701
Local Institution - 0023 Oklahoma City Oklahoma 73103-2433
Local Institution - 0022 Oklahoma City Oklahoma 79112
Local Institution - 0010 Duncansville Pennsylvania 16635
Local Institution - 0045 Orangeburg South Carolina 29118
Local Institution - 0021 Summerville South Carolina 29486
Local Institution - 0079 Jackson Tennessee 38305
Local Institution - 0001 Memphis Tennessee 38119
Local Institution - 0092 Colleyville Texas 76034
Local Institution Dallas Texas 75231
Local Institution - 0063 Houston Texas 77084
Local Institution - 0016 Mesquite Texas 75150
Local Institution - 0030 Plano Texas 75024
Local Institution - 0031 San Antonio Texas 78215
Local Institution Waco Texas 76710
Local Institution - 0083 Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04186871, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 15, 2024 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04186871 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →